Predicting the impact of Lynch syndrome-causing missense mutations from structural calculations

Predicting the impact of Lynch syndrome-causing missense mutations from structural calculations

• Sofie V. Nielsen,
• Amelie Stein,
• Alexander B. Dinitzen,
• Elena Papaleo,
• Michael H. Tatham,
• Esben G. Poulsen,
• Maher M. Kassem,
• Lene J. Rasmussen,
• Kresten Lindorff-Larsen ,
• Rasmus Hartmann-Petersen 

• Published: April 19, 2017
• https://doi.org/10.1371/journal.pgen.1006739

Abstract

Accurate methods to assess the pathogenicity of mutations are needed to fully leverage the possibilities of genome sequencing in diagnosis. Current data-driven and bioinformatics approaches are, however, limited by the large number of new variations found in each newly sequenced genome, and often do not provide direct mechanistic insight. Here we demonstrate, for the first time, that saturation mutagenesis, biophysical modeling and co-variation analysis, performed in silico, can predict the abundance, metabolic stability, and function of proteins inside living cells. As a model system, we selected the human mismatch repair protein, MSH2, where missense variants are known to cause the hereditary cancer predisposition disease, known as Lynch syndrome. We show that the majority of disease-causing MSH2 mutations give rise to folding defects and proteasome-dependent degradation rather than inherent loss of function, and accordingly our in silico modeling data accurately identifies disease-causing mutations and outperforms the traditionally used genetic disease predictors. Thus, in conclusion, in silico biophysical modeling should be considered for making genotype-phenotype predictions and for diagnosis of Lynch syndrome, and perhaps other hereditary diseases.

Last Posted: Apr 21, 2017

---

• Predicting the impact of Lynch syndrome-causing missense mutations from structural calculations  
  SV Nielsen et al, PLOS Genetics, April 2017
• Clinical Practice Guidelines for the Surgical Treatment of Patients With Lynch Syndrome.  
  Herzig Daniel O et al. Diseases of the colon and rectum 2017 Feb 60(2) 137-143
• Current and Future Role of Genetic Screening in Gynecologic Malignancies.  
  Ring Kari L et al. American journal of obstetrics and gynecology 2017 Apr
• Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.  
  Solomon Ilana et al. Journal of genetic counseling 2017 Jan
• Microsatellite analysis of sporadic and hereditary gynaecological cancer in routine diagnostics.  
  Libera Laura et al. Journal of clinical pathology 2017 Apr
• Expanding Lynch Syndrome Screening: From Research to Reality  
  View NCI R2R Webinar 1-hour presentation
• Living With Lynch syndrome: The Emotional Rollercoaster  
  by Guest Blogger Kristen Lummis, April 1, 2017
• Living With Lynch syndrome: The Emotional Rollercoaster  
  by Guest Blogger Kristen Lummis
• Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.  
  Masuda Kenta et al. Japanese journal of clinical oncology 2017 Dec 1-6
• Laboratory Assays in Evaluation of Lynch Syndrome in Patients with Endometrial Carcinoma.  
  Djordjevic Bojana et al. Surgical pathology clinics 2016 Jun 9(2) 289-99
• Lynch Syndrome on Health Report with Norman Swan on RN, Radio abc, March 20, 2017  
• Nashotah man behind Lynch Syndrome Awareness Day  
  A Budde, Lake Country Now, March 2017
• Lynch syndrome – highlighting recent and upcoming activities  
  M Clyne, Research to Reality Blog Post, March 2017
• Is there evidence that we should screen the general population for Lynch syndrome with genetic testing? A systematic review.  
  Prince Anya E R et al. Pharmacogenomics and personalized medicine 2017 1049-60
• Screening for Lynch Syndrome,  
  6abc, March 2, 2017
• March is Colorectal Cancer Awareness Month -- Do You Know About Lynch Syndrome?  
  G Hurst Blog post, Ambry Genetics, March 2, 2017

more